Clinical Trial Update: Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

Early-phase, multi-tracer PET imaging study combining [18F]Fluciclovine and 18F-FDG PET with advanced MRI for metabolic profiling in glioblastoma; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Axumin (fluciclovine F-18)
• FDG (fluorodeoxyglucose) (fluorodeoxyglucose)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Glioblastoma, Recurrent Glioblastoma | EARLY_Phase 1 | Status: RECRUITING